Plasma levels of C-reactive protein after coronary stent implantation
about
Role of C-reactive protein in cardiovascular diseasePredictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medicationClinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic diseaseCritical appraisal of C-reactive protein throughout the spectrum of cardiovascular diseasePrognostic Impact of 9-Month High-Sensitivity C-Reactive Protein Levels on Long-Term Clinical Outcomes and In-Stent Restenosis in Patients at 9 Months after Drug-Eluting Stent ImplantationImpact of C-reactive protein on in-stent restenosis: a meta-analysis.Prognostic value of plasma pentraxin-3 levels in patients with stable coronary artery disease after drug-eluting stent implantation.High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment.Current status of intravascular stents as delivery devices to prevent restenosis.Correlations between coronary plaque tissue composition assessed by virtual histology and blood levels of biomarkers for coronary artery disease.Inflammatory markers: linking unstable plaques to coronary event, an interventional perspective.Peri-procedural myocardial injury: 2005 update.Changes in anti-heat shock protein 27 antibody and C-reactive protein levels following cardiac surgery and their association with cardiac function in patients with cardiovascular disease.Inflammation as a marker for the prediction of internal carotid artery restenosis following eversion endarterectomy--evidence from clinical studies.Do statins have a role in reduction/prevention of post-PCI restenosis?Distinct yet complementary mechanisms of heparin and glycoprotein IIb/IIIa inhibitors on platelet activation and aggregation: implications for restenosis during percutaneous coronary intervention.C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction.Pre-procedural expression of Mac-1 and LFA-1 on leukocytes for prediction of late restenosis and their possible correlation with advanced coronary artery disease.Total sleep deprivation augments balloon angioplasty-induced neointimal hyperplasia in rats.Comparison of changes in circulating platelet-derived microparticles and platelet surface P-selectin expression after coronary stent implantation.Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation.Does a carbon ion-implanted surface reduce the restenosis rate of coronary stents?Increased C-reactive protein level after renal stent implantation in patients with atherosclerotic renal stenosis.C-reactive protein and myocardial infarction during percutaneous coronary intervention.Serum inflammatory and immune marker response after bare-metal or drug-eluting stent implantation following percutaneous coronary intervention.Impact of Omega-3 Supplementation on High Sensitive C-Reactive Protein Level and 30-Day Major Adverse Cardiac Events After the Implementation of Coronary Stent in Patients with Chronic Kidney Disease: A Randomized Clinical Study
P2860
Q28166927-13BA9CB7-22F6-416A-8547-36116B1492B4Q28213720-D5CF91D0-8B34-45C6-8F32-2058AD2FFDBBQ28218124-7DBA2DF6-A598-4C9A-BD67-1EF076E3CE0DQ28219483-3B935F4A-3444-4FB7-961E-29A30DD67389Q28548500-66F755F2-AF74-4EA4-9C3C-83C7318B54AEQ33693147-69D55BE3-41E9-44CE-AFEF-AB7DD89D9F69Q34694726-AB4D4BDD-919E-41DD-976B-695EECFD5540Q34973446-43BDF353-45F4-4D66-90AF-DB022C21F962Q35190217-38A3A8D3-8FA2-4F2C-A1A4-E3CA18FD69CEQ35932082-AC47196A-F2D6-45BA-8446-1D2DB43C8B52Q36251197-7C55EF95-406E-49B6-9151-5E5F4B160101Q36263844-44762EC5-B717-4E25-AD45-B0C0DAD75B69Q36428114-A08E7D80-0E67-445C-B9CB-22A2A9E9394FQ37923226-A9A7D082-0D92-4C2C-B90D-D1E05249B934Q37941867-0FEEEA8E-3DB5-4277-9963-3B5A2F18988FQ43013493-C555FF4E-C4C1-4510-BE34-D14B1D43CB35Q47191457-1175E561-25E6-4F56-AC82-0D76EEBAE525Q47949365-9FE8F3A7-9931-4530-9DCE-C8B4381FD298Q48288451-705B28FA-D569-466A-BCD0-B63711F64C56Q51132744-BD192A8F-E67C-4FA2-9869-14FE087FD4D3Q51370943-20288235-83CA-482B-8B54-895665590FB8Q51401456-568D3D1F-7D19-4D1E-9C19-8D36086055F9Q51613344-F2066134-4E91-4DB8-80B3-A9EA0BCBDB8DQ51729364-F79784B8-0A3A-466E-A156-350AD594EA78Q54655905-F4C967B5-8EC2-4896-98C3-8315693A06CFQ57136141-AC4A925D-07D7-40E4-BA59-24C9665F2F49
P2860
Plasma levels of C-reactive protein after coronary stent implantation
description
im Juli 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 July 2000
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2000
@uk
name
Plasma levels of C-reactive protein after coronary stent implantation
@en
Plasma levels of C-reactive protein after coronary stent implantation
@nl
type
label
Plasma levels of C-reactive protein after coronary stent implantation
@en
Plasma levels of C-reactive protein after coronary stent implantation
@nl
prefLabel
Plasma levels of C-reactive protein after coronary stent implantation
@en
Plasma levels of C-reactive protein after coronary stent implantation
@nl
P2093
P356
P1476
Plasma levels of C-reactive protein after coronary stent implantation
@en
P2093
Gottsauner-Wolf M
Hornykewycz S
Nikfardjam M
P304
P356
10.1053/EUHJ.1999.1987
P577
2000-07-01T00:00:00Z